MMRF
RTO icon

Michelson Medical Research Foundation’s Rentokil RTO Stock Holding History

Michelson Medical Research Foundation’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-457,815
Closed -$11M – 21
2025
Q2 		$11M Sell
457,815
-42,185
-8% -$978K 10.54% 3
2025
Q1 		$11.4M Buy
500,000
+320,000
+178% +$7.72M 9.58% 3
2024
Q4 		$4.56M Hold
180,000
– – 3.82% 12
2024
Q3 		$4.49M Buy
+180,000
New +$5.33M 3.16% 12

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Michelson Medical Research Foundation's RTO Position: Q3 2025 in Review

Michelson Medical Research Foundation sold out of Rentokil (RTO) in Q3 2025, closing a stake of 457,815 shares — an estimated $11M sold.

Michelson Medical Research Foundation first reported a position in RTO in Q3 2024 and held it in 4 quarters. The position peaked at $11.4M in Q1 2025. 213 funds tracked by Wall St. Rank hold RTO as of Q3 2025.

  • Michelson Medical Research Foundation reported no remaining Rentokil position as of Q3 2025 after selling out during the quarter.
  • Michelson Medical Research Foundation sold 457,815 Rentokil shares in Q3 2025, an estimated $11M.
  • Michelson Medical Research Foundation first reported a position in Rentokil in Q3 2024 and held it in 4 quarters.
  • Michelson Medical Research Foundation's Rentokil position peaked at $11.4M in Q1 2025.
  • 213 funds tracked by Wall St. Rank held Rentokil as of Q3 2025.

Based on Michelson Medical Research Foundation's 13F filing for Q3 2025, filed 14 Nov 2025.